| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/23/2004 | CN1154742C Recombinant MVA virus, and the use thereof |
| 06/23/2004 | CN1154741C Chimera gene with serveral herbicide resistant genes, plant cell and plant resistant to serveral herbicides |
| 06/23/2004 | CN1154740C Root cortex specific gene promoter |
| 06/23/2004 | CN1154738C Noval method for characterization of compounds which stimulate STF-1 expression in pancreatic islet cells |
| 06/23/2004 | CN1154737C Transgenic plants with altered senescence characteristics |
| 06/23/2004 | CN1154734C Mutated 5-enol pyruvylshikimate-3-phosphate sythase, gene coding for said protein and transformed plants containing said gene |
| 06/23/2004 | CN1154731C Gene of hop latent virus and methods for detecting the same |
| 06/23/2004 | CN1154728C Method for leading-in petunia transcription factor Pet SPL 2 gene to shorten inflorescence internode |
| 06/23/2004 | CN1154726C OB protein derivatives having prolonged half-life |
| 06/23/2004 | CN1154717C Improved immortalized human skin cell lines and novel serum-free medium useful for prodn. thereof |
| 06/22/2004 | US6753463 Transformed cotton plants |
| 06/22/2004 | US6753461 Method for increasing stress-resistance to a plant |
| 06/22/2004 | US6753460 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants |
| 06/22/2004 | US6753459 Genetic construct comprising a conditionally lethal gene operably associated with promoter functional in plant cell, gene being used to select, identify or selectively kill a plant expressing said gene |
| 06/22/2004 | US6753457 Activation of fetal nucleus; obtain cells, separate nucleus, incubate with activating egg extract, monitor fetal nucleus activity |
| 06/22/2004 | US6753424 Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents |
| 06/22/2004 | US6753419 Used for somatic gene therapy |
| 06/22/2004 | US6753412 Human Eag2 |
| 06/22/2004 | US6753314 Protein-protein complexes and methods of using same |
| 06/22/2004 | US6753313 Multimeric Apoa-I agonist compounds |
| 06/22/2004 | US6753182 Cryopreservation of plant cells |
| 06/22/2004 | US6753181 Generating organ tissue composed of interstitial structures; obtain organ, mechanically agitate in membrane stripping fluid, expose organ to sobulizing fluid, wash, recover organ; tissue engineering |
| 06/22/2004 | US6753178 For regenerating whole plants from calli or tissue |
| 06/22/2004 | US6753176 Genetic engineering; antiarthritic agents |
| 06/22/2004 | US6753166 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases |
| 06/22/2004 | US6753163 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 06/22/2004 | US6753161 Optoinjection methods |
| 06/22/2004 | US6753153 Markers for identification and isolation of pancreatic islet α and β progenitors |
| 06/22/2004 | US6753150 Detection of modulators of advanced glycation end product activity; obtain sample containing advanced glycation end product activity, incubate with peptide monitor adjustment in activity, adjustment in activity indicates modulator |
| 06/22/2004 | US6753146 System and method for evaluating agents which prevent oxidative damage |
| 06/22/2004 | US6753140 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 06/22/2004 | US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences |
| 06/22/2004 | CA2210620C Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen |
| 06/22/2004 | CA2194270C Method and system for cultivating cells particularly macrophages |
| 06/22/2004 | CA2159469C Two component fibrin glue |
| 06/22/2004 | CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
| 06/22/2004 | CA2059554C Fetal cell recovery method |
| 06/20/2004 | CA2453734A1 A thermoformed container for the culturing of cells |
| 06/20/2004 | CA2453723A1 Method for increasing protein content in plant cells |
| 06/19/2004 | CA2423904A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene |
| 06/17/2004 | WO2004050897A2 Methods for preparing antigen masked red blood cells having reduced hemolysis by sera |
| 06/17/2004 | WO2004050874A1 Germ-responsive promoter |
| 06/17/2004 | WO2004050865A1 Method for culturing neural stem cells using hepatocyte growth factor |
| 06/17/2004 | WO2004050864A1 Culture chamber for biologicals |
| 06/17/2004 | WO2004050855A2 Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
| 06/17/2004 | WO2004050848A2 Methods for antigen masking of red blood cells resulting in reduced hemolysis |
| 06/17/2004 | WO2004050842A2 Atm kinase compositions and methods |
| 06/17/2004 | WO2004050837A2 Treatment of dna damage related disorders |
| 06/17/2004 | WO2004050827A2 Cultured human pancreatic islets, and uses thereof |
| 06/17/2004 | WO2004050826A2 Method of dynamically culturing embryonic stem cells |
| 06/17/2004 | WO2004050709A2 Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media |
| 06/17/2004 | WO2004050706A2 Regulatory t-cells |
| 06/17/2004 | WO2004050680A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 06/17/2004 | WO2004050679A2 Mutant glycoproteins |
| 06/17/2004 | WO2004050117A1 Proteins involved in the regulation of energy homeostasis |
| 06/17/2004 | WO2004050029A2 Novel activated polyethylene glycol compounds |
| 06/17/2004 | WO2004050013A2 Material compositions and related systems and methods for treating cardiac conditions |
| 06/17/2004 | WO2004049914A2 Methods for reacting an antigen masking compound with red blood cells with high efficiency |
| 06/17/2004 | WO2004044003A3 Use of edg2 receptor in an animal model of heart failure |
| 06/17/2004 | WO2004035607A8 Human monoclonal antibodies against cd20 |
| 06/17/2004 | WO2004034013A8 Genotoxicity analysis |
| 06/17/2004 | WO2004018002A3 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 06/17/2004 | WO2004016742A3 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 06/17/2004 | WO2004015077A9 Compositions and methods for neural differentiation of embryonic stem cells |
| 06/17/2004 | WO2004011098A3 Golf shaft with adjustable stiffness and frequency |
| 06/17/2004 | WO2004007686A3 Methods and transgenic mouse model for identifying and modulating factors involved in the production of reactive oxygen intermediates |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003102213A3 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
| 06/17/2004 | WO2003075831A3 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 06/17/2004 | WO2003068357A3 Identification and high-yield isolation of human pancreatic islet progenitor and stem cells |
| 06/17/2004 | WO2003059259A3 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | WO2003015813A3 Anti-tumor vaccines |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | WO2002079419A3 Identifying and characterizing genes |
| 06/17/2004 | US20040117876 Dna; promoters for gene expression of plant cells |
| 06/17/2004 | US20040117869 Comprises nucleotide sequences coding oxidoreductase for use in increasing nornicotine biosynthesis in plants |
| 06/17/2004 | US20040117865 Transposon generated genetically engineered rodent for use as tool in clarifying gene function; gene therapy and transposon mediated transformation |
| 06/17/2004 | US20040117033 Method for composite cell-based implants |
| 06/17/2004 | US20040116678 Cardiac hypertrophy factor and uses therefor |
| 06/17/2004 | US20040116672 Human sel-10 polypeptides and polynucleotides that encode them |
| 06/17/2004 | US20040116369 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 06/17/2004 | US20040116364 antisense oligonucleotide that inhibits gene expression of death-associated protein kinase 1; diagnosis; kits; drug screening; use treating dysregulation of cellular apoptosis such as cancer |
| 06/17/2004 | US20040116335 Compositions and methods for inhibiting the proliferation and invasiveness of malignant cells comprising E-domain peptides of IGF-I |
| 06/17/2004 | US20040116032 Electroprocessed collagen |
| 06/17/2004 | US20040115813 Using differential colorimetric analysis to determine heterogeneity of tumors; diagnosis and characterization of poliferation products |
| 06/17/2004 | US20040115810 Stem cell differentiation-inducing promoter |
| 06/17/2004 | US20040115809 Propagating cytotoxic lymphocytes with specific toxicity in the presence of antigen presenting cells for use in treatment of tumors and viral infections; immunotherapy |
| 06/17/2004 | US20040115808 In vitro neuronal stem cell culture for transplantation and treatment of neurodegenerative and gastrointestinal diseases; tissue engineering |
| 06/17/2004 | US20040115807 O-2a progenitors multipotent cells from neurohypophysis |
| 06/17/2004 | US20040115806 Propagation of stable hippocampal culture using bone marrow stromal cells (BMSC) or umbilical mesenchymal cells for use in neuron transplantation and treatment of neurodegenerative diseases; tissue engineering |
| 06/17/2004 | US20040115805 CD56 positive human adult pancreatic endocrine progenitor cells |
| 06/17/2004 | US20040115804 Cell system for generating somatic cells |
| 06/17/2004 | US20040115801 Model epithelial cell cultures |
| 06/17/2004 | US20040115800 Expression vector comprising sequences which code for drug resistant cytidine deaminase and identify transduced and/or transfected cells; gene therapy; anticarcinogenic agnets; viricides |
| 06/17/2004 | US20040115789 Packaging cell lines for the continuous production of alphavirus vectors |